XGN
Exagen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$7.58
+0.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 15.03x
- Price / sales
- 2.58x
- Price / cash flow
- -28.26x
Enterprise value
- Enterprise value
- $184.6M
- EV / sales
- 2.60x
- EV / EBITDA
- -16.10x
- EV / EBIT
- -13.97x
- Market cap
- $183.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026